Shenzhen Beike Biotechnology Co., Ltd., Shenzhen, 518000, China.
Shenzhen Beike Biotechnology Co., Ltd., Shenzhen, 518000, China.
Stem Cell Res. 2024 Jun;77:103421. doi: 10.1016/j.scr.2024.103421. Epub 2024 Apr 15.
Peripheral blood mononuclear cell (PBMC) are recognized as a conveniently collected reprogramming resource. Several methods are available in academia to reprogram PBMC into induced pluripotent stem cells (iPSC). In this research, we reprogrammed PBMC of different genders by using non-integrative non-viral liposome electrotransfer containing the reprogramming factors OCT4, SOX2, KLF4, and c-MYC. The three obtained iPSC cell lines were karyotypically normal and showed significant tritiated differentiation potential in vitro and in vivo. Our study provided an efficient procedure for reprogramming PBMC into iPSC and obtained three well-functioning iPSC, that may contribute to advance personalized cell therapy in the future.
外周血单个核细胞(PBMC)被认为是一种方便采集的重编程资源。学术界有几种方法可将 PBMC 重编程为诱导多能干细胞(iPSC)。在这项研究中,我们使用含有重编程因子 OCT4、SOX2、KLF4 和 c-MYC 的非整合性非病毒脂质体电转技术,对不同性别来源的 PBMC 进行了重编程。获得的 3 株 iPSC 细胞系均具有正常核型,在体外和体内具有显著的放射性分化潜能。本研究为 PBMC 重编程为 iPSC 提供了一种有效的方法,并获得了 3 株功能良好的 iPSC,这可能有助于推动未来的个性化细胞治疗。